| P2093 | author name string | Kyung-Bok Lee | |
| | Dong-Ik Kim | |
| P2860 | cites work | Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis | Q24313372 |
| | Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells | Q24672061 |
| | Bone marrow cells regenerate infarcted myocardium | Q28210640 |
| | Peripheral arterial disease in the elderly: The Rotterdam Study | Q28263428 |
| | Mechanisms of angiogenesis and arteriogenesis | Q29617257 |
| | Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes | Q33222324 |
| | Human nerual stem cells for brain repair | Q33614725 |
| | Angiogenesis induced by autologous whole bone marrow stem cells transplantation. | Q33614740 |
| | Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development | Q33633524 |
| | Thromboangiitis obliterans (Buerger's disease). | Q33918391 |
| | Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases | Q34010216 |
| | Peripheral arterial disease--epidemiological aspects | Q34492461 |
| | Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population | Q34930923 |
| | Epidemiology of intermittent claudication in middle-aged men. | Q50602370 |
| | Intermittent claudication. A risk profile from The Framingham Heart Study. | Q50944777 |
| | Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs. | Q53582719 |
| | Update on Some Epidemiologic Features of Intermittent Claudication: The Framingham Study | Q56287924 |
| | Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) | Q56287926 |
| | The value of non-invasive techniques for the assessment of critical limb ischaemia | Q73293712 |
| | Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial | Q74811727 |
| | [Transplantation of autologous adult bone marrow stem cells in patients with severe peripheral arterial occlusion disease] | Q79795586 |
| | Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation | Q81647396 |
| | Adult stem cells for tissue repair - a new therapeutic concept? | Q35194623 |
| | Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis | Q35198652 |
| | Therapeutic angiogenesis in peripheral arterial disease: can biotechnology produce an effective collateral circulation? | Q35792010 |
| | ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascul | Q36426489 |
| | Arteriogenesis versus angiogenesis: similarities and differences | Q36430853 |
| | Peripheral arterial disease: diagnosis and management | Q37233217 |
| | Cell therapy in peripheral arterial disease | Q37279639 |
| | Mesenchymal stem cells for treatment of myocardial infarction. | Q38214090 |
| | Age-related Deterioration of Hematopoietic Stem Cells. | Q38214091 |
| | Angiogenesis facilitated by autologous whole bone marrow stem cell transplantation for Buerger's disease. | Q38511339 |
| | Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans | Q39342745 |
| | Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans. | Q39346993 |
| | Prevalence of peripheral arterial disease and its association with smoking in a population-based study in Beijing, China | Q39764579 |
| | Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised cl | Q40525372 |
| | Molecular mechanisms of coronary collateral vessel growth | Q41185967 |
| | The prevalence of peripheral arterial disease in a defined population | Q43564702 |
| | Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. | Q44450748 |
| | Therapeutic angiogenesis by autologous bone marrow cell implantation for refractory chronic peripheral arterial disease using assessment of neovascularization by 99mTc-tetrofosmin (TF) perfusion scintigraphy | Q45093502 |
| | Gene and stem cell therapies | Q45874350 |
| | Critical limb ischemia and stem cell research: anchoring hope with informed adverse event reporting | Q47584909 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 11-17 | |
| P577 | publication date | 2009-05-01 | |
| P1433 | published in | International journal of stem cells | Q26842430 |
| P1476 | title | Clinical application of stem cells for therapeutic angiogenesis in patients with peripheral arterial disease | |
| P478 | volume | 2 | |